Cargando…

Integrated multi‐omics profiling of high‐grade estrogen receptor‐positive, HER2‐negative breast cancer

Estrogen receptor‐positive and human epidermal growth factor receptor 2‐negative (ER(+)HER2(−)) breast cancer accounts for ~ 60–70% of all cases of invasive breast carcinoma. High‐grade ER(+)HER2(−) tumors respond poorly to endocrine therapy. In this study, we systematically analyzed clinical and mu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Kang, Li, Lun, Franch‐Expósito, Sebastià, Le, Xin, Tang, Jun, Li, Qing, Wu, Qianxue, Bassaganyas, Laia, Camps, Jordi, Zhang, Xiang, Li, Hongyuan, Foukakis, Theodoros, Xiang, Tingxiu, Wu, Jiong, Ren, Guosheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9208078/ https://www.ncbi.nlm.nih.gov/pubmed/34146382 http://dx.doi.org/10.1002/1878-0261.13043

Ejemplares similares

PCIG: a web-based application to explore immune–genomics interactions across cancer types
por: Pedrola, Anna, et al.
Publicado: (2022)

CNApp, a tool for the quantification of copy number alterations and integrative analysis revealing clinical implications
por: Franch-Expósito, Sebastià, et al.
Publicado: (2020)

Risk of hematologic malignancies after breast ductal carcinoma in situ treatment with ionizing radiation
por: Wang, Kang, et al.
Publicado: (2021)

Identification of autophagy‐related long non‐coding RNA prognostic signature for breast cancer
por: Wu, Qianxue, et al.
Publicado: (2021)

Epsin 3 potentiates the NF-κB signaling pathway to regulate apoptosis in breast cancer
por: Wu, Qianxue, et al.
Publicado: (2022)

Cyclooxygenase-2 in tumor-associated macrophages promotes breast cancer cell survival by triggering a positive-feedback loop between macrophages and cancer cells
por: Li, Hongzhong, et al.
Publicado: (2015)

The Potential Prognostic Role of Oligosaccharide-Binding Fold-Containing Protein 2A (OBFC2A) in Triple-Negative Breast Cancer
por: Wu, Qianxue, et al.
Publicado: (2021)

KRAB zinc-finger protein 382 regulates epithelial-mesenchymal transition and functions as a tumor suppressor, but is silenced by CpG methylation in gastric cancer
por: Pei, Lijiao, et al.
Publicado: (2018)

Clinical instability of breast cancer markers is reflected in long-term in vitro estrogen deprivation studies
por: Milosevic, Jelena, et al.
Publicado: (2013)

Long noncoding RNA LINC01089 predicts clinical prognosis and inhibits cell proliferation and invasion through the Wnt/β-catenin signaling pathway in breast cancer
por: Yuan, Hongfan, et al.
Publicado: (2019)

ZDHHC22-mediated mTOR palmitoylation restrains breast cancer growth and endocrine therapy resistance
por: Huang, Jiefeng, et al.
Publicado: (2022)

The epigenetically downregulated factor CYGB suppresses breast cancer through inhibition of glucose metabolism
por: Feng, Yixiao, et al.
Publicado: (2018)

Epigenetic silencing of the WNT antagonist Dickkopf 3 disrupts normal Wnt/β-catenin signalling and apoptosis regulation in breast cancer cells
por: Xiang, Tingxiu, et al.
Publicado: (2013)

The tumor suppressor interferon regulatory factor 8 inhibits β-catenin signaling in breast cancers, but is frequently silenced by promoter methylation
por: Luo, Xinrong, et al.
Publicado: (2017)

Phospholipase Cδ1 suppresses cell migration and invasion of breast cancer cells by modulating KIF3A-mediated ERK1/2/β- catenin/MMP7 signalling
por: Shao, Qing, et al.
Publicado: (2017)

Paired box 5 is a novel marker of breast cancers that is frequently downregulated by methylation
por: Li, Xia, et al.
Publicado: (2018)

A link between plasma membrane calcium ATPase 2 (PMCA2), estrogen and estrogen receptor α signaling in mechanical pain
por: Khariv, Veronika, et al.
Publicado: (2018)

Mutational Signatures in Cancer (MuSiCa): a web application to implement mutational signatures analysis in cancer samples
por: Díaz-Gay, Marcos, et al.
Publicado: (2018)

Benefits of neoadjuvant therapy compared with adjuvant chemotherapy for the survival of patients with HER2-positive breast cancer: A retrospective cohort study at FUSCC
por: Zheng, Shuyue, et al.
Publicado: (2022)

Estrogen Receptor, Progesterone Receptor, and HER2 Receptor Markers in Endometrial Cancer
por: Wang, Caifeng, et al.
Publicado: (2020)

The prognostic and predictive impact of low estrogen receptor expression in early breast cancer: a systematic review and meta-analysis
por: Paakkola, N.-M., et al.
Publicado: (2021)

Utilization of adipocyte-derived lipids and enhanced intracellular trafficking of fatty acids contribute to breast cancer progression
por: Yang, Dejuan, et al.
Publicado: (2018)

Epigenetic silencing of ADAMTS18 promotes cell migration and invasion of breast cancer through AKT and NF‐κB signaling
por: Xu, Hongying, et al.
Publicado: (2017)

Tumor suppressor DRD2 facilitates M1 macrophages and restricts NF-κB signaling to trigger pyroptosis in breast cancer
por: Tan, Yiqing, et al.
Publicado: (2021)

Cyclooxygenase-2 in tumor-associated macrophages promotes metastatic potential of breast cancer cells through Akt pathway
por: Gan, Lu, et al.
Publicado: (2016)

The novel 19q13 KRAB zinc-finger tumour suppressor ZNF382 is frequently methylated in oesophageal squamous cell carcinoma and antagonises Wnt/β-catenin signalling
por: Zhang, Chong, et al.
Publicado: (2018)

Metabonomics-based omics study and atherosclerosis
por: Wu, Duo-jiao, et al.
Publicado: (2011)

Zinc-Finger Protein 545 Inhibits Cell Proliferation as a Tumor Suppressor through Inducing Apoptosis and is Disrupted by Promoter Methylation in Breast Cancer
por: Xiao, Yun, et al.
Publicado: (2014)

GeMSTONE: orchestrated prioritization of human germline mutations in the cloud
por: Chen, Siwei, et al.
Publicado: (2017)

Evaluation of Estrogen and Progesterone Receptors and Her-2 Expression with Grading in the Fine-needle Aspirates of Patients with Breast Carcinoma
por: Toi, Pampa Ch, et al.
Publicado: (2018)

The interplay between eosinophils and T cells in breast cancer immunotherapy
por: Zerdes, Ioannis, et al.
Publicado: (2023)

The new 6q27 tumor suppressor DACT2, frequently silenced by CpG methylation, sensitizes nasopharyngeal cancer cells to paclitaxel and 5-FU toxicity via β-catenin/Cdc25c signaling and G2/M arrest
por: Zhang, Yan, et al.
Publicado: (2018)

Dynamic evaluation of the immune infiltrate and immune function genes as predictive markers for neoadjuvant chemotherapy in hormone receptor positive, HER2 negative breast cancer
por: Matikas, Alexios, et al.
Publicado: (2018)

Clinicopathological Characteristics and Breast Cancer–Specific Survival of Patients With Single Hormone Receptor–Positive Breast Cancer
por: Li, Yunhai, et al.
Publicado: (2020)

HER2 positivity is not associated with adverse prognosis in high-risk estrogen receptor-positive early breast cancer patients treated with chemotherapy and trastuzumab
por: Li, Shuai, et al.
Publicado: (2020)

A novel double antibody sandwich-lateral flow immunoassay for the rapid and simple detection of hepatitis C virus
por: XIANG, TINGXIU, et al.
Publicado: (2012)

DACT2 silencing by promoter CpG methylation disrupts its regulation of epithelial-to-mesenchymal transition and cytoskeleton reorganization in breast cancer cells
por: Xiang, Tingxiu, et al.
Publicado: (2016)

Zinc-finger protein 545 is inactivated due to promoter methylation and functions as a tumor suppressor through the Wnt/β-catenin, PI3K/AKT and MAPK/ERK signaling pathways in colorectal cancer
por: Xiang, Shili, et al.
Publicado: (2017)

Programmed death‐ligand 1 gene expression is a prognostic marker in early breast cancer and provides additional prognostic value to 21‐gene and 70‐gene signatures in estrogen receptor‐positive disease
por: Zerdes, Ioannis, et al.
Publicado: (2020)

A Novel Multi-Omics Analysis Model for Diagnosis and Survival Prediction of Lower-Grade Glioma Patients
por: Wu, Wei, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3pcffjufun3lohhu7ac00r9fqd